Search

Your search keyword '"Liedtke, Cornelia"' showing total 231 results

Search Constraints

Start Over You searched for: Author "Liedtke, Cornelia" Remove constraint Author: "Liedtke, Cornelia" Database Unpaywall Remove constraint Database: Unpaywall
231 results on '"Liedtke, Cornelia"'

Search Results

1. Adressen

2. AGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2024

4. Update Mammakarzinom 2023 Teil 2 – Brustkrebs in fortgeschrittenen Krankheitsstadien

5. Update Mammakarzinom 2023 Teil 3 – Expertenmeinungen zu Brustkrebs in frühen Krankheitsstadien

8. Update Breast Cancer 2023 Part 3 – Expert Opinions of Early Stage Breast Cancer Therapies

9. Adressen

10. Update Breast Cancer 2023 Part 1 – Early Stage Breast Cancer

11. Update Breast Cancer 2023 Part 2 – Advanced-Stage Breast Cancer

12. Efficacy of Endocrine Therapy Plus Trastuzumab and Pertuzumab vs De-escalated Chemotherapy in Patients with Hormone Receptor–Positive/ERBB2-Positive Early Breast Cancer

13. Lymphödem

14. Supplementary Figure from De-escalated Neoadjuvant Chemotherapy in Early Triple-Negative Breast Cancer (TNBC): Impact of Molecular Markers and Final Survival Analysis of the WSG-ADAPT-TN Trial

15. Anthracycline-containing and taxane-containing chemotherapy for early-stage operable breast cancer: a patient-level meta-analysis of 100 000 women from 86 randomised trials

16. "Supplementary Table S5 from Impact of RNA Signatures on pCR and Survival after 12-Week Neoadjuvant Pertuzumab plus Trastuzumab with or without Paclitaxel in the WSG-ADAPT HER2+/HR− Trial

17. CCR Translation on this Article from Molecular Characterization of Breast Cancer with High-Resolution Oligonucleotide Comparative Genomic Hybridization Array

20. Supplementary Data from Molecular Characterization of Breast Cancer with High-Resolution Oligonucleotide Comparative Genomic Hybridization Array

21. Supplementary Data from Molecular Characterization of Breast Cancer with High-Resolution Oligonucleotide Comparative Genomic Hybridization Array

22. Abstract P1-09-04: Comparison of length and quality of life (QoL) and the side effects of therapy between breast conserving surgery with intraoperative radiotherapy (TARGIT-IORT) versus mastectomy for in-breast-recurrence of breast cancer

23. Abstract PD11-03: PD11-03 Comparison of a mono Atezolizumab window followed by Atezolizumab and chemotherapy with Atezolizumab and chemotherapy in triple negative breast cancer – an interim analysis of the adaptive randomized neoadjuvant trial NeoMono

24. Update Breast Cancer 2022 Part 5 – Early Stage Breast Cancer

25. Update Breast Cancer 2022 Part 6 – Advanced-Stage Breast Cancer

26. Update Mammakarzinom 2022 Teil 4 – Brustkrebs in fortgeschrittenen Krankheitsstadien

27. AGO-Empfehlungen zur operativen Therapie des Mammakarzinoms: Update 2022

29. Arbeitsgemeinschaft Gynäkologische Onkologie Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2023

30. AGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2023

31. CDK4/6 Inhibitors in Advanced HR+/HER2 – Breast Cancer: A Multicenter Real-World Data Analysis

33. Update Mammakarzinom 2022 Teil 3 – Brustkrebs in frühen Krankheitsstadien

34. Impact of RNA Signatures on pCR and Survival after 12-Week Neoadjuvant Pertuzumab plus Trastuzumab with or without Paclitaxel in the WSG-ADAPT HER2+/HR− Trial

36. AGO Recommendations for the Surgical Therapy of Breast Cancer: Update 2022

37. Impact of stromal tumor-infiltrating lymphocytes (sTILs) on response to neoadjuvant chemotherapy in triple-negative early breast cancer in the WSG-ADAPT TN trial

38. Update Breast Cancer 2022 Part 4 – Advanced-Stage Breast Cancer

39. Einsatz von CDK4/6-Inhibitoren beim fortgeschrittenen HR+/HER2- Mammakarzinom – eine multizentrische „Real world“ Datenanalyse – 1. Klaus-Dieter-Schulz-Versorgungsforschungspreis – eine Kurzübersicht

40. Update Breast Cancer 2022 Part 3 – Early-Stage Breast Cancer

41. Breast preservation after local recurrence of breast cancer: Comparison of length and quality of life (QoL) between breast conserving surgery with intraoperative radiotherapy (TARGIT-IORT) versus mastectomy.

42. Update Mammakarzinom 2021 Teil 4 – Prävention und frühe Krankheitsstadien

44. Practice-Changing Perspectives regarding Systemic Therapy in Early Breast Cancer: Opinions of German Experts regarding the 17th St. Gallen International Consensus Conference

45. Update Mammakarzinom 2021 Teil 2 – fortgeschrittene Stadien, Langzeitfolgen und Biomarker

46. Update Mammakarzinom 2021 Teil 3 – aktuelle Entwicklungen bei der Behandlung von Brustkrebspatientinnen mit frühen Krankheitsstadien: Übersicht und Beurteilung von speziellen Therapiesituationen durch ein internationales Expertenpanel

47. AGO-Empfehlungen zur operativen Therapie der Axilla nach neoadjuvanter Chemotherapie: Update 2021

48. Abstract OT2-29-01: neoMono - An adaptive randomized neoadjuvant two arm trial in patients with TNBC comparing a mono atezolizumab window followed by atezolizumab and chemotherapy with atezolizumab and chemotherapy

49. Abstract P3-19-16: Impact of targeted intraoperative (TARGIT-IORT) tumor bed boost during breast conserving surgery for early breast cancer on breast cancer associated and non-breast cancer associated mortality and morbidity

50. Update Breast Cancer 2021 Part 5 – Advanced Breast Cancer

Catalog

Books, media, physical & digital resources